159 related articles for article (PubMed ID: 31016331)
1. EANM Focus 1: one small step for two men, one giant leap for a specialty.
Fanti S; Oyen WJG
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1400-1401. PubMed ID: 31016331
[No Abstract] [Full Text] [Related]
2. Molecular Imaging and Theranostics in Pancreatic Neuroendocrine Tumours: From a Luminous Present to an Even Brighter Future.
Paola M; Mansi L
Curr Radiopharm; 2019; 12(2):93-95. PubMed ID: 31362647
[No Abstract] [Full Text] [Related]
3. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
4. Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.
Czernin J
J Nucl Med; 2019 Aug; 60(8):1037. PubMed ID: 31371618
[No Abstract] [Full Text] [Related]
5. Prostate Cancer Imaging and Therapy: Potential Role of Nanoparticles.
Kilcoyne A; Harisinghani MG; Mahmood U
J Nucl Med; 2016 Oct; 57(Suppl 3):105S-110S. PubMed ID: 27694162
[TBL] [Abstract][Full Text] [Related]
6. Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy.
Fahey F; Zukotynski K; Jadvar H; Capala J;
J Nucl Med; 2015 Jul; 56(7):1119-29. PubMed ID: 25999432
[No Abstract] [Full Text] [Related]
7. XXXV Congress of the SEMNIM. Highlights.
Serena Puig A
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):400-11. PubMed ID: 26296646
[No Abstract] [Full Text] [Related]
8. Theranostic Outcomes in Clinical Practice of Oncology: What, So What, Now What? What's More.
Turner JH
Cancer Biother Radiopharm; 2019 Apr; 34(3):135-140. PubMed ID: 30973278
[No Abstract] [Full Text] [Related]
9. SNMMI industry forum created to work together on areas of promise.
J Nucl Med; 2015 Mar; 56(3):13N. PubMed ID: 25733601
[No Abstract] [Full Text] [Related]
10. SNMMI leadership update: reaching out to develop a unified voice.
Herscovitch P
J Nucl Med; 2015 Mar; 56(3):16N. PubMed ID: 25733604
[No Abstract] [Full Text] [Related]
11. Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.
Langbein T; Weber WA; Eiber M
J Nucl Med; 2019 Sep; 60(Suppl 2):13S-19S. PubMed ID: 31481583
[TBL] [Abstract][Full Text] [Related]
12. Highlights lecture EANM 2016: "Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine".
Aboagye EO; Kraeber-Bodéré F
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1559-1574. PubMed ID: 28597119
[TBL] [Abstract][Full Text] [Related]
13. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
[TBL] [Abstract][Full Text] [Related]
14. Clinical research: the future of the molecular imaging technologist-a white paper presented by members of the graduate stakeholders committee of the SNMMI technologist section.
Holbrook S; Baldwin J; Gilmore CD; Henkin R; Hubble W; Kiss C; Bires AM; Mann A; Nelson KP; Owen MA; Sobey K; Stuckey A; Wenzel-Lamb N; Wilkinson D; Wintering NA
J Nucl Med Technol; 2014 Sep; 42(3):228-32. PubMed ID: 25125447
[No Abstract] [Full Text] [Related]
15. [PET Group of the SEMN (Spanish Society of Nuclear Medicine): continuity of the pathway].
Cabrera Villegas A
Rev Esp Med Nucl; 2006; 25(3):157-8. PubMed ID: 16762268
[No Abstract] [Full Text] [Related]
16. The Spanish Society of Nuclear Medicine and Molecular Imaging, a a solid and growing society.
Prats Rivera E
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):279-80. PubMed ID: 23928284
[No Abstract] [Full Text] [Related]
17. Paradigm shift in theranostics of neuroendocrine tumors: conceptual horizons of nanotechnology in nuclear medicine.
Arora G; Bandopadhyaya G
Ann Nucl Med; 2018 Apr; 32(3):151-164. PubMed ID: 29374820
[TBL] [Abstract][Full Text] [Related]
18. [Not Available].
Rofo; 2017 Dec; 189(12):1175-1176. PubMed ID: 29156459
[No Abstract] [Full Text] [Related]
19. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
20. EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours-the consensus in a nutshell.
Kunikowska J; Ambrosini V; Herrmann K
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1276-1277. PubMed ID: 33624150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
